Doug H Bache Insider Profile
4 Followers
Doug H Bache, Director at PharmaCielo, holds 0.00 shares in PharmaCielo (Ticker: PCLOF), holds 1.20M shares in Marathon Gold (Ticker: MGDPF), holds 608.83K shares in Treasury Metals (Ticker: TSE:NEXG). Most recently, Doug H Bache Sold ― shares of PharmaCielo on Sep 02, 2026 for an estimated value of $3.85K.
Profitable Transactions
4 out of 9 Profitable Transactions
Average Return
+91.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Marathon Gold
(MGDPF)
(MGDPF)
Rating:Informative Buy
Date:Mar 15, 2016 - Mar 15, 2017
Return:+434.40%
The most profitable trade made by Doug H Bache
Doug H Bache's Trading History
PharmaCielo
Sep 02, 2026
Director
Informative Sell
3.85K
$0.00
Marathon Gold
May 04, 2022
―
Uninformative Sell
162.00K
$714.28K
Treasury Metals
―
Director
―
C$931.51K
List of latest transactions for each holding click on a transaction to see Doug H Bache's performance on stock
You May Also Like
Doug H Bache insider profile FAQ
What is the percentage of profitable transactions made by Doug H Bache?
The percentage of profitable transactions made by Doug H Bache is 44%.
What is the average return per transaction made by Doug H Bache?
The average return per transaction made by Doug H Bache is 91.70%.
What stocks does Doug H Bache hold?
Doug H Bache holds: PCLOF, MGDPF, TSE:NEXG stocks.
What was Doug H Bache’s latest transaction?
Doug H Bache latest transaction was an Informative Sell of $3.85K.
What was Doug H Bache's most profitable transaction?
Doug H Bache’s most profitable transaction was an Informative Buy of MGDPF stock on March 15, 2016. The return on the trade was 434.40%.
What is Doug H Bache's role in PharmaCielo?
Doug H Bache's role in PharmaCielo is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.